Paul Zachary Lamberty: Final Debarment Order
Published Date: 2/6/2026
Notice
Summary
Paul Zachary Lamberty is officially banned for 10 years from importing any drugs into the U.S. because he was convicted of serious crimes involving fake and misleading drugs. He didn’t respond to the FDA’s chance to defend himself, so the ban starts on February 6, 2026. If he wants to end the ban early, he can apply anytime but must be careful about sharing private info.
Analyzed Economic Effects
3 provisions identified: 0 benefits, 2 costs, 1 mixed.
10-Year Import Ban for Lamberty
Paul Zachary Lamberty is banned for 10 years from importing or offering for import any drug into the United States. The debarment is effective February 6, 2026 and is based on his May 30, 2025 federal felony convictions for conspiracy and introduction of misbranded drugs with intent to defraud and mislead.
Importing With Lamberty Is Prohibited
Importing or offering for import any drug into the United States by, with the assistance of, or at the direction of Paul Zachary Lamberty is a prohibited act under section 301(cc) of the FD&C Act. This prohibition is effective February 6, 2026.
Termination Application & Confidentiality Rules
Mr. Lamberty may apply at any time to ask for early termination of the debarment under section 306(d)(1) of the FD&C Act. Applications submitted electronically will be posted publicly, so confidential information must be submitted as a written/paper submission following the FDA instructions to protect confidential material.
Personalized for You
How does this regulation affect your finances?
Personalize government policy and PRIA will tell you what this federal register document means for your household, plus every other regulation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-16296, Substances Generally Recognized as Safe
The Food and Drug Administration (FDA or we) is proposing to require the submission of generally recognized as safe (GRAS) notices for the use of a human or animal food substance purported to be GRAS under the conditions of its intended use under the Federal Food, Drug, and Cosmetic Act (FD&C Act).
2026-14073, Drug Establishment Registration and Drug Listing Requirements for Establishments Engaged in Distributed Manufacturing and Certain Foreign Establishments
The FDA wants to make it easier for drug makers who work in several locations to register as one company instead of many. They’re also updating rules for foreign drug companies to match new laws about handling health threats. If you’re in drug manufacturing, get ready to comment by September 11, 2026, and keep an eye on possible paperwork changes that could affect your business.
2026-13047, Establishment Registration and Product Listing for Tobacco Products
The FDA wants to make sure all tobacco product makers, both in the U.S. and abroad, register their businesses and list their products. This new rule closes a big gap by including foreign companies, helping the FDA keep better track of tobacco products for public health. Comments on this proposal are open until September 14, 2026, so affected businesses should get ready to update their info and possibly face new costs.
2026-16714, Agency Information Collection Activities; Proposed Collection; Comment Request; Third Party Disclosure and Recordkeeping Requirements for Reportable Food
The Food and Drug Administration (FDA or the Agency) is announcing an opportunity for public comment on the proposed collection of certain information by the Agency. Under the Paperwork Reduction Act of 1995 (PRA), Federal Agencies are required to publish notice in the Federal Register concerning each proposed collection of information, including each proposed extension of an existing collection of information, and to allow 60 days for public comment in response to the notice. This notice solicits comments on the information collection provisions of FDA's third-party disclosure and recordkeeping requirements for reportable food.
2026-16712, Agency Information Collection Activities; Proposed Collection; Comment Request; Imports and Electronic Import Entries
The FDA wants your thoughts on how they collect info about imports and electronic import entries. If you’re involved in importing goods, this could affect you! They’re asking for comments by October 16, 2026, to help improve the process without adding extra costs or hassle.
2026-16715, Agency Information Collection Activities; Proposed Collection; Comment Request; Investigational New Drug Application Requirements
The Food and Drug Administration (FDA) is announcing that a proposed collection of information has been submitted to the Office of Management and Budget (OMB) for review and clearance under the Paperwork Reduction Act of 1995.
Previous / Next Documents
Previous: 2026-02336, Agency Information Collection Activities; Proposed eCollection eComments Requested; Extension of Currently Approved Collection: Title-Campus Program Grantee Needs and Progress Assessment Tool
The Department of Justice’s Office on Violence Against Women is asking for more time to keep using a survey tool that helps campus program grantees track their needs and progress. They want your feedback on how this tool works and how to make it easier to use. If you’re involved in these programs, you can share your thoughts by April 7, 2026—no extra costs, just a chance to improve the process!
Next: 2026-02339, Codex Alimentarius Commission: Meeting of the Codex Committee on Methods of Analysis and Sampling
The U.S. Codex Office is hosting a public video meeting on February 19, 2026, to share info and gather feedback on food testing and sampling rules before the big Codex meeting in Hungary in March. This affects food producers, labs, and anyone interested in food safety standards. Joining the meeting and submitting comments helps shape U.S. positions, with no costs but important deadlines to keep in mind.